PTIXW
Protagenic Therapeutics, Inc.newWarrants of Protagenic Therapeutics, Inc.new · PTIX stock page →
$0.6480 −0.07 (−10.00%)
Oct 26 4:00 PM ET · prev $0.7200
1 year
−78.3%
from $2.98 · Oct 27
30 days
−16.9%
from $0.7800
52-week range
$0.1280–2.98
−78% from high · low Jul 29
Avg volume 20D
1.0K
Oct 1 spike 5.7K
New fund stakes
0
Q1 2025 13F · 0 exits
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2025: 1 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
21% below its 50-day average.
Who's buying
13F· Q1 20250
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $21.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current Q | — | — | — | $0.00 |
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Mar 31, 2025 Inst.
UBS Group AG — DOUBLED
3,000 shares ($21.00)